EFFECT OF OBESITY AND WEIGHT-LOSS ON ARGININE VASOPRESSIN RESPONSE TO METOCLOPRAMIDE AND NICOTINE FROM CIGARETTE-SMOKING

被引:10
作者
CHIODERA, P
CAPRETTI, L
DAVOLI, C
CAIAZZA, A
BIANCONI, L
COIRO, V
机构
[1] OSPED CODOGNO,CODOGNO,ITALY
[2] OSPED CREMONA,DIV MED GEN,CREMONA,ITALY
[3] OSPED FIDENZA,DIV MED GEN,FIDENZA,ITALY
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1990年 / 39卷 / 08期
关键词
D O I
10.1016/0026-0495(90)90119-W
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have previously reported an impaired arginine vasopressin (AVP) response to insulin-induced hypoglycemia in obese men, suggesting a hypothalamic-posterior pituitary disorder in obesity. In the present study, we examined the AVP response to other releasing stimuli with a central site of action. The AVP response of 10 obese men to metoclopramide (MCP) or nicotine inhaled with cigarette smoking was compared with that obtained in eight sex- and age-matched controls. The AVP increase during nicotine and MCP tests were significantly lower in the obese patients than in the normal controls. Obese men were restudied after substantial weight loss. The AVP response to nicotine and MCP administration was significantly higher than before slimming and did not differ from that observed in the normal weight subjects. These results demonstrate obesity-related alterations in the AVP responsiveness to nicotine inhaled with cigarette smoking and MCP, supporting the hypothesis for a hypothalamic-posterior pituitary disorder in obesity. © 1990.
引用
收藏
页码:783 / 786
页数:4
相关论文
共 16 条
[1]   METOCLOPRAMIDE - PHARMACOLOGY AND CLINICAL-APPLICATION [J].
ALBIBI, R ;
MCCALLUM, RW .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (01) :86-95
[2]   ARGININE VASOPRESSIN RESPONSE TO INSULIN-INDUCED HYPOGLYCEMIA IN MAN [J].
BAYLIS, PH ;
ZERBE, RL ;
ROBERTSON, GL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 53 (05) :935-940
[3]   POSTERIOR PITUITARY-FUNCTION IN HEALTH AND DISEASE [J].
BAYLIS, PH .
CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1983, 12 (03) :747-770
[4]   VASOPRESSIN RELEASE BY NICOTINE - SITE OF ACTION [J].
BISSET, GW ;
FELDBERG, W ;
GUERTZENSTEIN, PG ;
SILVA, MRE .
BRITISH JOURNAL OF PHARMACOLOGY, 1975, 54 (04) :463-474
[5]   NALOXONE DECREASES THE INHIBITING EFFECT OF ETHANOL ON THE RELEASE OF ARGININE-VASOPRESSIN INDUCED BY CIGARETTE-SMOKING IN MAN [J].
CHIODERA, P ;
DAMATO, L ;
DAVOLI, C ;
VOLPI, R ;
DELSIGNORE, R ;
GNUDI, A ;
COIRO, V .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1987, 36 (08) :804-806
[6]   SIMULTANEOUS RADIOIMMUNOASSAY FOR PLASMA ARGININE-VASOPRESSIN AND OXYTOCIN USING DEAE SEPHADEX - A 25 EXTRACTION [J].
CHIODERA, P ;
LOUIS, F ;
LEGROS, JJ .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1984, 7 (04) :287-293
[7]   MUSCARINIC CHOLINERGIC, BUT NOT SEROTONINERGIC MEDIATION OF ARGININE VASOPRESSIN RESPONSE TO METOCLOPRAMIDE IN MAN [J].
COIRO, V ;
CAPRETTI, L ;
SPERONI, G ;
VOLPI, R ;
FAGNONI, F ;
BIANCONI, L ;
SCHIANCHI, L ;
CAIAZZA, A ;
CHIODERA, P .
CLINICAL ENDOCRINOLOGY, 1989, 31 (04) :491-498
[8]   EFFECT OF OBESITY AND WEIGHT-LOSS ON THE ARGININE VASOPRESSIN RESPONSE TO INSULIN-INDUCED HYPOGLYCEMIA [J].
COIRO, V ;
CHIODERA, P .
CLINICAL ENDOCRINOLOGY, 1987, 27 (02) :253-258
[9]  
COIRO V, 1986, METABOLISM, V34, P577
[10]   ROLE OF VASOPRESSIN AND PROLACTIN IN ABNORMAL SALT AND WATER METABOLISM OF OBESE PATIENTS BEFORE AND AFTER FASTING AND DURING REFEEDING [J].
DRENICK, EJ ;
CARLSON, HE ;
ROBERTSON, GL ;
HERSHMAN, JM .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1977, 26 (03) :309-317